Resolution of danazol-induced cholestasis with S-adenosylmethionine

Gary Bray, Bray GP, G P Bray, J M Tredger, J. Michael Tredger, Tredger JM, R Williams, Williams R, Roger Williams
Postgraduate medical journal · 1993 · vol. 69(809) , pp. 237–239 · doi:10.1136/pgmj.69.809.237 · PMID:8497444 · PMC2399730 · W2140059783
Case report OA: bronze CC0 ⤵ 4 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Intravenous and oral S-adenosylmethionine treatment resolved jaundice and renal impairment in a patient experiencing danazol-induced cholestasis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In a case of danazol-induced cholestasis, the anti-cholestatic agent S-adenosylmethionine was given intravenously for 3 weeks and then orally for 6 weeks. This was well tolerated and led to prompt resolution of both jaundice and associated renal impairment.

My notes (saved in your browser only)

MeSH descriptors

Cholestasis Danazol S-Adenosylmethionine Administration, Oral Cholestasis Cholestasis Danazol Humans Infusions, Intravenous Male Middle Aged S-Adenosylmethionine Time Factors

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (17)

Cited by (4)

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
openalex
last seen: 2026-05-10T11:14:42.433795+00:00
pubmed
last seen: 2026-10-08T21:59:37.277143+00:00
License: CC0 · commercial use OK